Why is whole genome sequencing with NGS uniquely applicable to patients with NSCLC?

Why is whole genome sequencing with NGS uniquely applicable to patients with NSCLC?

Why is whole genome sequencing with NGS uniquely applicable to patients with NSCLC?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Dr. Daniel SW Tan

Dr. Daniel SW Tan

Medical Oncology
Senior Consultant
National Cancer Centre Singapore
Clinician-Scientist Fellow, The Genome Institute
Singapore